These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7116193)

  • 41. Synaptic localization of alpha-bungarotoxin binding which blocks nicotinic transmission at frog sympathetic neurons.
    Marshall LM
    Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1948-52. PubMed ID: 6972045
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preparation of neurotoxic 3H-beta-bungarotoxin: demonstration of saturable binding to brain synapses and its inhibition by toxin I.
    Othman IB; Spokes JW; Dolly JO
    Eur J Biochem; 1982 Nov; 128(1):267-76. PubMed ID: 7173209
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Profile of the alpha-bungarotoxin-binding regions on the extracellular part of the alpha-chain of Torpedo californica acetylcholine receptor.
    Mulac-Jericevic B; Atassi MZ
    Biochem J; 1987 Dec; 248(3):847-52. PubMed ID: 3435488
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Heterogeneity of acetylcholine receptors: different forms of receptor distinguished by alpha-bungarotoxin kinetics and by antibody binding properties.
    Massa T; Mittag TW
    J Pharmacol Exp Ther; 1983 Nov; 227(2):340-8. PubMed ID: 6631716
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Distribution of an alpha-bungarotoxin-binding cholinergic nicotinic receptor in rat brain.
    Segal M; Dudai Y; Amsterdam A
    Brain Res; 1978 Jun; 148(1):105-19. PubMed ID: 656919
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nicotinic acetylcholine receptor subtypes in human frontal cortex: changes in Alzheimer's disease.
    Sugaya K; Giacobini E; Chiappinelli VA
    J Neurosci Res; 1990 Nov; 27(3):349-59. PubMed ID: 2097379
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Radiolabeled alpha-bungarotoxin derivatives: kinetic interaction with nicotinic acetylcholine receptors.
    Lukas RJ; Morimoto H; Hanley MR; Bennett EL
    Biochemistry; 1981 Dec; 20(26):7373-8. PubMed ID: 7326232
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of [(3)H]CHIBA-1001 binding to alpha7 nicotinic acetylcholine receptors in the brain from rat, monkey, and human.
    Tanibuchi Y; Wu J; Toyohara J; Fujita Y; Iyo M; Hashimoto K
    Brain Res; 2010 Aug; 1348():200-8. PubMed ID: 20537987
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Some observations on the binding patterns of alpha-bungarotoxin in the central nervous system of the rat.
    Hunt S; Schmidt J
    Brain Res; 1978 Nov; 157(2):213-32. PubMed ID: 719523
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of putative nicotinic acetylcholine receptors solubilized from rat brains.
    Sugiyama H; Yamashita Y
    Brain Res; 1986 May; 373(1-2):22-6. PubMed ID: 2424552
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anti-acetylcholine receptor antibodies directed against the alpha-bungarotoxin binding site induce a unique form of experimental myasthenia.
    Gomez CM; Richman DP
    Proc Natl Acad Sci U S A; 1983 Jul; 80(13):4089-93. PubMed ID: 6575398
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Localization of 3H-nicotine, 125I-kappa-bungarotoxin, and 125I-alpha-bungarotoxin binding to nicotinic sites in the chicken forebrain and midbrain.
    Sorenson EM; Chiappinelli VA
    J Comp Neurol; 1992 Sep; 323(1):1-12. PubMed ID: 1430311
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Postmortem stability of alpha-bungarotoxin binding sites in mouse and human brain.
    Davies P; Feisullin S
    Brain Res; 1981 Jul; 216(2):449-54. PubMed ID: 7248786
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cholinergic agonist-induced down regulation of neuronal alpha-bungarotoxin receptors.
    Messing A
    Brain Res; 1982 Jan; 232(2):479-84. PubMed ID: 7188033
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro autoradiographic studies of 3H-alpha-bungarotoxin and 3H-quinuclidinylbenzilate binding in rat hind limb muscles.
    Gillberg PG; Aquilonius SM; Askmark H; Liljeborg A
    Acta Physiol Scand; 1984 Apr; 120(4):617-20. PubMed ID: 6485834
    [No Abstract]   [Full Text] [Related]  

  • 56. In vitro binding characteristics of [3H]AZ11637326, a novel alpha7-selective neuronal nicotinic receptor agonist radioligand.
    Gordon JC; Phillips E; Gurley DA; Heys JR; Lazor LA; Barthlow HG; Mallamaci MA; Keith RA
    Eur J Pharmacol; 2010 Oct; 645(1-3):63-9. PubMed ID: 20674564
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alpha-bungarotoxin and the competing antibody WF6 interact with different amino acids within the same cholinergic subsite.
    Conti-Tronconi BM; Diethelm BM; Wu XD; Tang F; Bertazzon T; Schröder B; Reinhardt-Maelicke S; Maelicke A
    Biochemistry; 1991 Mar; 30(10):2575-84. PubMed ID: 2001347
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Binding of alpha-bungarotoxin to isolated alpha subunit of the acetylcholine receptor of Torpedo californica: quantitative analysis with protein blots.
    Gershoni JM; Hawrot E; Lentz TL
    Proc Natl Acad Sci U S A; 1983 Aug; 80(16):4973-7. PubMed ID: 6576369
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Alpha-bungarotoxin receptors in the CNS.
    Morley BJ
    Prog Brain Res; 1989; 79():101-8. PubMed ID: 2587737
    [No Abstract]   [Full Text] [Related]  

  • 60. Pharmacological characterization of [(125)I]CHIBA-1006 binding, a new radioligand for α7 nicotinic acetylcholine receptors, to rat brain membranes.
    Wu J; Toyohara J; Tanibuchi Y; Fujita Y; Zhang J; Chen H; Matsuo M; Wang RF; Hashimoto K
    Brain Res; 2010 Nov; 1360():130-7. PubMed ID: 20816767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.